Skip to content
★ Sign in to follow
CH

Chris H. Takimoto

IGM Biosciences, Inc.
Total declarations
46
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (23 ops.)
€8.4M

Latest filing published 17 Sept 2024 for IGM Biosciences, Inc., €15k.

Filing timeline

BuySale
Chris H. Takimoto

Insider track record

Disclosed buys
0
Disclosed sells
23

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Chris H. Takimoto: trading record in brief

Chris H. Takimoto discloses dealings in 2 companies, chiefly Forty Seven, Inc. and IGM Biosciences, Inc. Over a trading history stretching from 4 January 2019 to 13 September 2024, the count stands at 46 filings.

Sales make up the whole of the open-market record (23 sales, €8.4M). Besides market trades, the filings include 10 share grants and 12 option exercises. 2024 to date brings no purchases and 4 sales.

On 17 September 2024 came the latest disclosure, an open-market sale for €15k in IGM Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Chris H. Takimoto

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations